MPG   Logo Psychiatrie
institut
Welcome to the Max Planck Institute of Psychiatry in Munich

The Institute is aiming to provide outstanding basic and clinical research, as well as clinical service on psychiatric and neurological disorders.
Our mission is a better understanding of diseases such as depression and anxiety to subsequent improve diagnostic procedures and therapies.

NEWS


Press release:

01.02.2010
Suicide risk of depressive patients increasing with genetic disposition
Research into genetic causes of suicidal behaviour of depressive patients associates variants of tyrosin kinase 2 receptor gene (NTRK2) with an elevated risk of attempted suicide. As a binding site for the factor BDNF (brain derived neurotrophic factor), NTRK2 has an important function for a target-oriented setting up of networks of nerve cells and thus for a well-balanced neuronal communication. With the newly-discovered mutations, the scientists of the Max Planck Institute of Psychiatry have established the study of the molecular causes of suicidal behaviour....